Rick Doblin’s 50-Year Battle to Transform Trauma Treatment with Psychedelics
For more than five decades, Rick Doblin, Ph.D., has been on a relentless mission to integrate psychedelics into mainstream medicine. As the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), he has pioneered research into the therapeutic potential of MDMA, psilocybin, and other substances to help individuals suffering from PTSD, trauma, and mental health disorders.
In this episode of Greater Good Radio, Doblin dives deep into the history, science, and future of psychedelic-assisted therapy. His journey is a testament to perseverance, scientific curiosity, and an unwavering belief in the power of these substances to heal.
The Origins of MAPS: Reclaiming Psychedelics for Healing
Doblin’s fascination with psychedelics began in the early 1970s when, at the age of 18, he experienced LSD for the first time. Unlike the fear-driven narratives he had grown up with, his experience revealed a deeper, more profound perspective on human consciousness and healing. However, the U.S. government had already begun its war on drugs, classifying psychedelics as dangerous substances with no medical benefit.
In 1986, in response to the DEA’s ban on MDMA, Doblin founded MAPS with a clear goal: to bring back psychedelic research and establish a legal framework for their therapeutic use. The name “MAPS” was intentionally designed to include “psychedelic” in an academic and scientific context, helping to reclaim the term from its association with counterculture.
Over the years, MAPS has been at the forefront of clinical research, funding groundbreaking studies on MDMA-assisted therapy for PTSD and advocating for drug policy reform. Despite government pushback, regulatory hurdles, and public skepticism, Doblin remained committed to proving the medical benefits of these substances through rigorous scientific research.
MDMA Therapy and the Fight Against PTSD
One of the most remarkable contributions of MAPS has been its research into MDMA-assisted therapy for PTSD. In clinical trials, MDMA has shown unprecedented success rates in helping individuals process and overcome trauma.
Doblin shared powerful stories of healing, including a man who had suffered from deep trauma for over 40 years following a terrifying LSD experience. Through MDMA therapy, he was finally able to face his past, process his emotions, and regain trust in himself—something traditional therapies had failed to achieve.
These clinical trials have led to FDA breakthrough therapy designation, and while an advisory panel recently rejected its approval, Doblin remains optimistic that regulatory approval is on the horizon. His vision is not just about medicalization but also responsible access for personal and spiritual growth.
Psychedelics Beyond Therapy: Reforming Drug Policy
Beyond the medical realm, Doblin has been a strong advocate for policy change. He argues that the war on drugs has been counterproductive, racially biased, and has fueled mass incarceration while failing to reduce substance abuse.
In the interview, he discussed his vision for licensed legalization, where individuals would be granted the right to use psychedelics responsibly—similar to obtaining a driver’s license. This approach would allow safe access while minimizing abuse and harm. He also highlighted the growing role of psychedelic churches, like the Church of Ambrosia, where communities gather to use substances like psilocybin in a ceremonial context.
Doblin believes that, just as Western medicine once dismissed alternative therapies, psychedelics are now at a turning point. The research speaks for itself, and public perception is shifting.
A Legacy of Healing and Transformation
As the conversation wrapped up, Doblin reflected on his lifelong mission:
“What would I want my great-great-grandchild to remember about me? That I had this vision to create a more loving, healthy world—to help people heal their traumas—and that I pursued that for the rest of my life.”
For 50 years, Rick Doblin has fought against stigma, bureaucracy, and skepticism to bring psychedelics back into the realm of legitimate medicine. With MAPS leading the way, the future of mental health treatment looks more promising than ever. Whether through MDMA for PTSD, psilocybin for depression, or holistic psychedelic-assisted therapy, Doblin’s work has already changed countless lives—and his battle is far from over.
CLICK HERE to SUBSCRIBE to our YouTube channel
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | RSS